Lenore D. Williams - 28 Feb 2023 Form 4/A Insider Report for Fidelity National Information Services, Inc. (FIS)

Role: CEVP, Chief People Officer
Signature: /s/ Matthew Ricciardi, attorney-in-fact for Lenore D. Williams
Issuer symbol: FIS
Transactions as of: 28 Feb 2023
Net transactions value: +$10,436,360
Form type: 4/A
Filing time: 01 Mar 2024, 16:14:41 UTC
Date Of Original Report: 02 Mar 2023
Previous filing: 07 Feb 2023
Next filing: 03 Apr 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FIS	Stock Option (Right to Buy)	Award	$2,942,384	+40,373	$72.88	40,373	28 Feb 2023	Common Stock	40,373	$72.88	Direct	F1, F2
transaction	FIS	Stock Option (Right to Buy)	Award	$3,572,688	+45,104	$79.21	45,104	28 Feb 2023	Common Stock	45,104	$79.21	Direct	F1, F2
transaction	FIS	Stock Option (Right to Buy)	Award	$3,921,288	+47,600	$82.38	47,600	28 Feb 2023	Common Stock	47,600	$82.38	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023.
F2	The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.

Content

In a Form 4 filed on March 2, 2023, the reporting person reported receipt of a grant of premium stock options on February 28, 2023 that would vest and become exercisable over three years with a different premium exercise price for each vested tranche. These options should have been reported as three separate grants (rather than one consolidated grant in the same aggregate amount), with 15%, 25%, and 30% premium exercise prices to the closing price on February 28, 2023 of $63.37, and each vesting and becoming exercisable in three equal installments over three years. There were no additional grants of premium stock options made to reporting person in fiscal 2023.

The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.